UCalgary News: UCeed-funded company develops revolutionary asthma treatment
UCalgary researchers find game-changing alternative to inhalers
Inhalers may no longer be the only option in treating acute asthma attacks thanks to research by a UCalgary professor and his medical company supported by the UCeed program.
Research led by Dr. Richard Wilson, PhD, points to a novel oral treatment for asthma that goes beyond the traditional inhaler. The new treatment is likely to be fast-acting, targeting the nervous system rather than the airways. Wilson’s lab has shown that the carotid bodies, tiny collections of neurons on each side of the neck, may be responsible for triggering an allergen-induced asthma attack.